595 related articles for article (PubMed ID: 16383238)
1. [Study on the burden of abnormal hematopoietic clone of the patients with myelodysplastic syndromes and its implications].
Wang HQ; Shao ZH; Shi J; Cao YR; Liu H; Bai J; Tu MF; Xing LM; Cui ZZ; Liu SH; Sun J; Jia HR; Yang TY
Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):473-6. PubMed ID: 16383238
[TBL] [Abstract][Full Text] [Related]
2. Burden of abnormal hematopoietic clone in patients with myelodysplastic syndromes.
Wang HQ; Shao ZH; Shi J; Cao YR; Liu H; Bai J; Tu MF; Xing LM; Cui ZZ; Liu SH; Sun J; Jia HR; Yang TY
Chin Med Sci J; 2006 Jun; 21(2):99-103. PubMed ID: 16845796
[TBL] [Abstract][Full Text] [Related]
3. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome.
Zheng Z; Qianqiao Z; Qi H; Feng X; Chunkang C; Xiao L
Exp Hematol; 2010 Aug; 38(8):677-84. PubMed ID: 20394797
[TBL] [Abstract][Full Text] [Related]
4. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
5. [Study of Th cell subsets in bone marrow of myelodysplastic syndromes patients].
Wang XL; Shao ZH; Yao C; He GS; Liu H; Shi J; Bai J; Cao YR; Tu MF; Wang HQ; Xing LM; Sun J; Jia HR; Yang CL
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):743-5. PubMed ID: 16620580
[TBL] [Abstract][Full Text] [Related]
6. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
Zhang F; Hao Y; Pang W
Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
[TBL] [Abstract][Full Text] [Related]
7. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].
Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY
Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary study of biological characteristics of myelodysplastic syndromes clonal cells].
Li X; Wu LY; Ying SX; Chang CK; He Q; Song LQ; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):478-83. PubMed ID: 18072633
[TBL] [Abstract][Full Text] [Related]
9. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of regulatory T cells in patients with myelodysplastic syndrome.
Hamdi W; Ogawara H; Handa H; Tsukamoto N; Nojima Y; Murakami H
Eur J Haematol; 2009 Mar; 82(3):201-7. PubMed ID: 19018862
[TBL] [Abstract][Full Text] [Related]
12. [Clonal chromosomal aberrations in patients with aplastic anemia at the disease onset and transformation].
Ol'shanskaia IuV; Mikhaĭlova EA; Domracheva EV; Udovichenko AI; Davidian IuR; Vodinskaia LA; Zakharova AV; Kokhno AV; Kaplanskaia IB; Tikhonova LIu; Tsvetaeva NV; Parovichnikova EN; Savchenko VG
Ter Arkh; 2006; 78(7):31-4, 36-7. PubMed ID: 16944748
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of continuous karyotyping in myelodysplastic syndromes].
Lai YY; Qiu JY; Zhang Y; Zhang Y; Shi Y; He Q; Dang H; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):645-8. PubMed ID: 15634565
[TBL] [Abstract][Full Text] [Related]
14. DNA content of granulocytes, monocytes, and lymphocytes in the bone marrow smears of patients with myelodysplastic syndromes.
Widell S; Hast R; Cox C; Auer G; Bennett JM
Am J Hematol; 2001 Jun; 67(2):112-8. PubMed ID: 11343383
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of IGF-IR in malignant clonal cells in bone marrow of myelodysplastic syndromes.
He Q; Li X; Zhang Z; Zhang Q; Xu F; Yang L; Tao Y; Liu Y
Cancer Invest; 2010 Dec; 28(10):983-8. PubMed ID: 20569071
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes.
Xu F; Li X; Wu L; He Q; Zhang Z; Chang C
Br J Haematol; 2010 May; 149(4):587-97. PubMed ID: 20331463
[TBL] [Abstract][Full Text] [Related]
18. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
19. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.
Fozza C; Contini S; Galleu A; Simula MP; Virdis P; Bonfigli S; Longinotti M
Exp Hematol; 2009 Aug; 37(8):947-55. PubMed ID: 19409953
[TBL] [Abstract][Full Text] [Related]
20. [Apoptotic characteristics of CD34 positive cells in myelodysplastic syndromes].
Li X; Pu Q; Liu YZ; Tao Y; Ying SX; Jiang QY; Shi J
Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):355-7. PubMed ID: 12941189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]